14:37 ยท 2 June 2026

Oracle and Alphabet shares fall amid AI funding concerns ๐Ÿ“‰

Oracle (ORCL.US) shares fell more than 4% in premarket trading on Tuesday, giving back part of the nearly 10% gain recorded during the previous session. The decline was not driven by weaker company fundamentals, but rather by growing investor concerns about the cost of expanding artificial intelligence infrastructure. Alphabet (GOOGL.US) shares also fell nearly 3% after the company announced plans to raise approximately $80 billion through a stock offering to finance investments in next-generation technologies.

Key Takeaways

  • Oracle is down more than 4% in premarket trading after its shares reached their highest levels since November during the previous session.

  • Alphabet plans to raise $80 billion through a stock sale, with the proceeds earmarked for AI infrastructure investments.

  • Investors are increasingly focusing not only on AI's growth potential, but also on the massive capital required to support it.

Alphabet Highlights the Scale of AI Spending

The trigger for Oracle's decline was Alphabet's announcement of an $80 billion equity offering. Berkshire Hathaway is expected to participate in the deal with an investment of roughly $10 billion. The capital raised will be used to expand data-center capacity and computing infrastructure needed to meet growing demand for AI services.

The move highlights just how expensive the race for AI leadership has become. Back in April, Alphabet increased its projected capital expenditure budget for the year to as much as $190 billion. For investors, this serves as a reminder that success in AI depends not only on technology and customer demand, but also on access to enormous amounts of capital.

Why Are Investors Reacting Through Oracle?

For Oracle, the AI boom may be a double-edged sword. On one hand, the company benefits from rising demand for cloud infrastructure and enterprise software solutions. On the other hand, investors are beginning to question how long technology companies can continue financing massive AI investments without putting pressure on margins, balance sheets, or future capital-raising needs.

As a result, the market is increasingly focused not only on which companies stand to benefit from artificial intelligence, but also on which firms may ultimately bear the largest costs of building the infrastructure behind it.

Source: xStation5

9 June 2026, 15:15

Market Wrap: The โ€œBullsโ€ Are Back on the European Trading Floor ๐Ÿ’ฅ

8 June 2026, 22:06

Apple shares fall amid WWDC conference ๐Ÿ“‰ No AI breakthrough?

8 June 2026, 18:30

The World Cup on the Market: Is There an Opportunity for Profit?

8 June 2026, 17:57

Intel gains 10% after talks with Google and Nvidia

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.